» Articles » PMID: 39817361

Care Pathway for Patients Hospitalized with Venous Thromboembolism

Overview
Publisher Wiley
Date 2025 Jan 16
PMID 39817361
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a potentially fatal disease with a multifactorial nature, impacting different medical and surgical specialties. Recently, new guidelines and direct oral anticoagulants facilitated early discharge for most DVT patients and non-severe PE patients.

Objective: The aim of this study is to illustrate the distribution of VTE patients throughout the hospital and map their care pathway from Emergency Department (ED) to hospital discharge.

Methods: This multicenter retrospective cross-sectional study included all hospitalized patients with a VTE code from 39 hospitals between 2018 and 2019. Data were analysed using JupyterLab, with subgroup analyses based on mode of entry, diagnosis location and thrombosis site.

Results: A total of 23,199 hospitalizations were analysed, involving 17,718 patients a median age 66 years [52-78] and man-to-women ratio 1.05. Among these, 10,747(46.3%) had PE and 4176(18.0%) had lower limb DVT. The ED was the primary entry point for 31.2% of cases, followed by gastroenterology, surgery, geriatrics, and internal medicine. Patients admitted through ED patients were most frequently transferred to internal medicine, cardiovascular and intensive care units (ICU). The median hospital stay was 9 days [4-21], with ICU stays being the longest (mean 15 days [8-27]). Notably, 1357 patients (18.8%) of VTE patients were discharged within 48 h of ED admission.

Conclusions: This study is the first to portray the distribution and care pathways of VTE patients across hospital departments. Despite recent clinical guidelines, many patients still require inpatient management, highlighting the need for dedicated care pathway.

Citing Articles

Care pathway for patients hospitalized with venous thromboembolism.

Mahe I, Skaff Y, Helfer H, Benarroch S, Happe F, Remaki A Eur J Clin Invest. 2025; 55(4):e14383.

PMID: 39817361 PMC: 11891819. DOI: 10.1111/eci.14383.

References
1.
Mansour S, Alotaibi G, Wu C, Sean McMurtry M . Trends in admission rates and in-hospital stay for venous thromboembolism. Thromb Res. 2017; 156:149-154. DOI: 10.1016/j.thromres.2017.06.012. View

2.
Sanchez O, Roy P, Gaboreau Y, Schmidt J, Moustafa F, Benmaziane A . Home treatment for patients with cancer-associated venous thromboembolism. Arch Cardiovasc Dis. 2023; 117(1):16-28. DOI: 10.1016/j.acvd.2023.11.012. View

3.
Kline J, Kahler Z, Beam D . Outpatient treatment of low-risk venous thromboembolism with monotherapy oral anticoagulation: patient quality of life outcomes and clinician acceptance. Patient Prefer Adherence. 2016; 10:561-9. PMC: 4841397. DOI: 10.2147/PPA.S104446. View

4.
Hawes E . Patient Education on Oral Anticoagulation. Pharmacy (Basel). 2018; 6(2). PMC: 6025075. DOI: 10.3390/pharmacy6020034. View

5.
Keller K, Schmitt V, Hahad O, Espinola-Klein C, Munzel T, Lurz P . Categorization of Patients With Pulmonary Embolism by Charlson Comorbidity Index. Am J Med. 2024; 137(8):727-735. DOI: 10.1016/j.amjmed.2024.04.025. View